Global Efficacy Study of MPC-7869 to Treat Patients With Alzheimer's

NCT00322036 · clinicaltrials.gov ↗
PHASE3
Phase
TERMINATED
Status
800
Enrollment
INDUSTRY
Sponsor class

Stopped Myriad has discontinued the development of Flurizan.

Conditions

Interventions

Sponsor

Myrexis Inc.